Oxford Immunotec Global PLC (OXFD, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Oxford Immunotec Global PLC is a high-growth diagnostics company. It is engaged in developing and commercializing proprietary tests for the management of immune-regulated conditions. Its platform includes T-SPOT technology platform. Oxford Immunotec Global PLC has a market cap of $463.482 million; its shares were traded at around $17.53 with a P/E ratio of 3.92 and P/S ratio of 4.90. Oxford Immunotec Global PLC had annual average EBITDA growth of 26.00% over the past five years.
For the last quarter Oxford Immunotec Global PLC reported a revenue of $15.4 million, compared with the revenue of $25.03 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $59.8 million, a decrease of 42% from the previous year. For the last five years Oxford Immunotec Global PLC had an average revenue growth rate of 14.3% a year.
The reported diluted earnings per share was $4.56 for the year, compared with the loss per share of $1.28 in the previous year. The Oxford Immunotec Global PLC had an operating margin of -33.2%, compared with the operating margin of -27.88% a year before. The 10-year historical median operating margin of Oxford Immunotec Global PLC is -38.51%. The profitability rank of the company is 3 (out of 10).
At the end of the fiscal year, Oxford Immunotec Global PLC has the cash and cash equivalents of $192.8 million, compared with $90.3 million in the previous year. The long term debt was $0.11 million, compared with $29.9 million in the previous year. Oxford Immunotec Global PLC has a financial strength rank of 8 (out of 10).
At the current stock price of $17.53, Oxford Immunotec Global PLC is traded at 36.3% premium to its historical median P/S valuation band of $12.86. The P/S ratio of the stock is 4.90, while the historical median P/S ratio is 3.61. The stock gained 40.35% during the past 12 months.
Directors and Officers Recent Trades:
- SVP & General Counsel Elizabeth M Keiley sold 4,100 shares of OXFD stock on 03/04/2019 at the average price of $17. The price of the stock has increased by 3.12% since.
For the complete 20-year historical financial data of OXFD, click here.
